4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane

C23H33BrN4O2 — CID 166162521

IUPAC4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane
SMILESCCCC1(COc2nc(N3CCCOCC3)c3ccc(Br)c(C)c3n2)CCCN1C
InChIInChI=1S/C23H33BrN4O2/c1-4-9-23(10-5-11-27(23)3)16-30-22-25-20-17(2)19(24)8-7-18(20)21(26-22)28-12-6-14-29-15-13-28/h7-8H,4-6,9-16H2,1-3H3
InChIKeyZJGMYRIKAUEAFH-UHFFFAOYSA-N
MW477.45 g/mol
LogP4.57
Rot. Bonds6

About 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane

4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane (PubChem CID 166162521) has the molecular formula C23H33BrN4O2 and a molecular weight of 477.45 g/mol. Its IUPAC name is 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane.

Molecular Properties

Compound Name4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane
PubChem CID166162521
Molecular FormulaC23H33BrN4O2
Molecular Weight477.45 g/mol
Exact Mass476.18
IUPAC Name4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane
SMILESCCCC1(COc2nc(N3CCCOCC3)c3ccc(Br)c(C)c3n2)CCCN1C
InChIInChI=1S/C23H33BrN4O2/c1-4-9-23(10-5-11-27(23)3)16-30-22-25-20-17(2)19(24)8-7-18(20)21(26-22)28-12-6-14-29-15-13-28/h7-8H,4-6,9-16H2,1-3H3
InChIKeyZJGMYRIKAUEAFH-UHFFFAOYSA-N
XLogP4.57
TPSA50.72 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500477.45
LogP ≤ 54.57
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-8-methyl-4-(1,4-oxazepan-4-yl)quinazolin-7-yl]naphthalen-2-ol
CID 166162533
2-[2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-8-methyl-4-(1,4-oxazepan-4-yl)quinazoline-7-carboximidoyl]aniline
CID 166162635
[(1S)-1-[[7-bromo-6-chloro-8-methyl-4-(1,4-oxazepan-4-yl)quinazolin-2-yl]oxymethyl]-2,2-difluorocyclopropyl]methoxy-tert-butyl-dimethylsilane
CID 170967700
4-(7-bromo-2-chloro-8-fluoroquinazolin-4-yl)-1,4-oxazepane
CID 166162600
(3R)-1-[2-[[(4aS,7aR)-1-methyl-3,4,5,6,7,7a-hexahydro-2H-cyclopenta[b]pyridin-4a-yl]methoxy]-7-bromo-8-fluoroquinazolin-4-yl]-3-methylpiperidin-3-ol
CID 170956880
4-[7-chloro-8-fluoro-2-[[(2R,8S)-2-methoxy-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]-1,4-oxazepane
CID 176594058
7-[3-chloro-2-(trifluoromethoxy)phenyl]-4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]pyrido[4,3-d]pyrimidine
CID 156645612
5-ethynyl-6-fluoro-4-[8-fluoro-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-4-(1,4-oxazepan-4-yl)quinazolin-7-yl]naphthalen-2-ol
CID 166162594
5-ethyl-6-fluoro-4-[8-fluoro-4-(1,4-oxazepan-4-yl)-2-[(1-propyl-3,4,5,6,7,7a-hexahydro-2H-cyclopenta[b]pyridin-4a-yl)methoxy]pyrido[4,3-d]pyrimidin-7-yl]naphthalen-2-ol
CID 176662129
5-ethynyl-6-fluoro-4-[8-fluoro-2-[[(2R)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]-4-(1,4-oxazepan-4-yl)quinazolin-7-yl]naphthalen-2-ol
CID 166162629
4-[4-(1,1-dioxo-1,4-thiazinan-4-yl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-ylmethoxy)-8-methylquinazolin-7-yl]naphthalen-2-ol
CID 166162612
4-[7-chloro-5-ethoxy-8-fluoro-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-4-yl]-1,4-oxazepane
CID 176594350

Frequently Asked Questions

What is the IUPAC name of 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane?
The IUPAC name of 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane (CID 166162521) is 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane.
What is the SMILES notation for 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane?
The canonical SMILES for 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane is CCCC1(COc2nc(N3CCCOCC3)c3ccc(Br)c(C)c3n2)CCCN1C.
What is the InChIKey of 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane?
The InChIKey is ZJGMYRIKAUEAFH-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H33BrN4O2/c1-4-9-23(10-5-11-27(23)3)16-30-22-25-20-17(2)19(24)8-7-18(20)21(26-22)28-12-6-14-29-15-13-28/h7-8H,4-6,9-16H2,1-3H3.
What are the key properties of 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane?
4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane has a molecular weight of 477.45 g/mol, XLogP of 4.57, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[7-bromo-8-methyl-2-[(1-methyl-2-propylpyrrolidin-2-yl)methoxy]quinazolin-4-yl]-1,4-oxazepane is sourced from PubChem (CID 166162521), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).